We have completed a third-party allotment of capital. While aiming to increase the number of N-NOSE tests and improve the consultation rate, we will promote our business with the immediate goal of putting the next-generation cancer type specific tests into practical use.
HIROTSU BIO SCIENCE Corporation is proud to announce the opening of a store on Tmall Global, the largest cross-border EC platform in China opera . . .
2023.08.22Hirotsu Bio Science Inc. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Takaaki Hirotsu) has signed a memorandum of understanding wi . . .
2023.06.13On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .
2023.03.20